Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
A three sequence, open-label, multi-center, prospective, study in stable kidney transplant
patients to assess and compare the pharmacokinetics (Cmax, C24, and AUC), and safety of
LCP-Tacro (tacrolimus) tablets versus Prograf (tacrolimus) capsules.